Lv2
190 积分 2025-07-15 加入
Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis
1个月前
已完结
Visceral Fat Accumulation During Lipid Overfeeding Is Related to Subcutaneous Adipose Tissue Characteristics in Healthy Men
1个月前
已完结
Determinants of ectopic liver fat in metabolic disease
1个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
2个月前
已完结
The 25-item Dizziness Handicap Inventory was shortened for use in general practice by 60 percent
2个月前
已完结
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial
2个月前
已完结
Review of current and new drugs for the treatment of metabolic-associated fatty liver disease
2个月前
已完结
Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
2个月前
已完结
Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver
2个月前
已完结
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals
3个月前
已完结
皖公网安备34019202002308
